For example, the expression of HSPA8 and HSPH1 could be increased and related to good prognosis of patients with their mutations in uterine corpus endometrial carcinoma; HSPA12A mutation in lung adenocarcinoma could down-regulate its expression and lead to poor prognosis (Table 4). This evidence concerns the gene HSPA12A and uterine corpus endometrial carcinoma.